Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 354,171 | 135,029 | 49,397 | 58,226 | 66,927 |
| Marketable Securities | 147,325 | 331,830 | 405,394 | 382,632 | 368,249 |
| Receivables | 24,513 | 33,512 | 29,352 | 28,805 | 30,497 |
| Inventories | 1,105 | 1,194 | 1,590 | 1,496 | 1,290 |
| TOTAL | $533,707 | $519,292 | $507,106 | $496,895 | $492,268 |
| Non-Current Assets | |||||
| PPE Net | 2,333 | 2,573 | 2,594 | 2,746 | 2,917 |
| Intangibles | 18,186 | 18,565 | 18,944 | 19,323 | 19,702 |
| Other Non-Current Assets | 90,306 | 93,817 | 93,144 | 90,138 | 88,671 |
| TOTAL | $110,825 | $114,955 | $114,682 | $112,207 | $111,290 |
| Total Assets | $644,532 | $634,247 | $621,788 | $609,102 | $603,558 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 35,092 | 45,551 | 50,125 | 50,236 | 51,394 |
| Other current liabilities | 58,702 | 45,885 | 42,498 | 38,164 | 39,348 |
| TOTAL | $93,794 | $91,436 | $92,623 | $88,400 | $90,742 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 14,999 | 15,613 | 13,508 | 12,153 | 10,693 |
| TOTAL | $14,999 | $15,613 | $13,508 | $12,153 | $10,693 |
| Total Liabilities | $108,793 | $107,049 | $106,131 | $100,553 | $101,435 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 57,444 | 56,785 | 56,590 | 56,561 | 56,490 |
| Common Shares | 57 | 57 | 57 | 57 | 56 |
| Retained earnings | -154,649 | -157,901 | -164,762 | -168,032 | -170,606 |
| Other shareholders' equity | -255 | -1,193 | -1,485 | -1,431 | -1,328 |
| TOTAL | $535,739 | $527,198 | $515,657 | $508,549 | $502,123 |
| Total Liabilities And Equity | $644,532 | $634,247 | $621,788 | $609,102 | $603,558 |